Researcher.Life Logo

Current Computer-Aided Drug Design : Impact Factor & More

eISSN: 1875-6697pISSN: 1573-4099

Key Metrics

CiteScore
2.1
Impact Factor
< 5
SJR
Q4Drug Discovery
SNIP
0.45
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Computer-Aided Drug Design

Current Computer-Aided Drug Design Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Computer-Aided Drug Design ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Computer-Aided Drug Design

Luteolin as a Multitarget Agent against Colorectal Cancer Explored Through Integrative Network Pharmacology, Molecular Docking, and Dynamics Simulations.
  • 13 May 2026
  • Current computer-aided drug design
A Hybrid FT-TRF Approach for Diabetes-related Compound Identification.
  • 10 May 2026
  • Current computer-aided drug design
MTK5R6E: A Novel Natural Inhibitor of P-loop Residues of Thymidylate Monophosphate Kinase from Mycobacterium tuberculosis.
  • 8 May 2026
  • Current computer-aided drug design
Integrating Multi-omics, Mendelian Randomization, and Experimental Validation to Unveil the Role of Traditional Chinese Medicine in Postmenopausal Osteoporosis.
  • 8 May 2026
  • Current computer-aided drug design
Identification of Selective Mtb-DHFR Inhibitors as Antitubercular Agents: A Fragment Merging Approach.
  • 6 May 2026
  • Current computer-aided drug design
From IPI-549 to Novel Compounds: A Novel Strategy Integrating 3D-QSAR, Scaffold Growth, Molecular Docking, and Molecular Dynamics Simulation in PI3Kγ Inhibitor Design.
  • 5 May 2026
  • Current computer-aided drug design
Luteolin as a Multitarget Agent against Colorectal Cancer Explored Through Integrative Network Pharmacology, Molecular Docking, and Dynamics Simulations.
  • 13 May 2026
  • Current computer-aided drug design
A Hybrid FT-TRF Approach for Diabetes-related Compound Identification.
  • 10 May 2026
  • Current computer-aided drug design
MTK5R6E: A Novel Natural Inhibitor of P-loop Residues of Thymidylate Monophosphate Kinase from Mycobacterium tuberculosis.
  • 8 May 2026
  • Current computer-aided drug design
Integrating Multi-omics, Mendelian Randomization, and Experimental Validation to Unveil the Role of Traditional Chinese Medicine in Postmenopausal Osteoporosis.
  • 8 May 2026
  • Current computer-aided drug design
Identification of Selective Mtb-DHFR Inhibitors as Antitubercular Agents: A Fragment Merging Approach.
  • 6 May 2026
  • Current computer-aided drug design
From IPI-549 to Novel Compounds: A Novel Strategy Integrating 3D-QSAR, Scaffold Growth, Molecular Docking, and Molecular Dynamics Simulation in PI3Kγ Inhibitor Design.
  • 5 May 2026
  • Current computer-aided drug design

FAQs on Current Computer-Aided Drug Design